Medical News

RSS

WHO says H1N1 remains pandemic

WHO Director-General Margaret Chan on Thursday announced the WHO still considers H1N1 (swine) flu a pandemic, despite the fact "its most intense activity has passed in many parts of the world," Reuters reports (Lynn, 6/3).

4 Jun 2010

Delicate balance of microbes in vagina can vary between healthy women: New study

The delicate balance of microbes in the vagina can vary greatly between healthy women, according to a new study led by the University of Maryland School of Medicine's Institute for Genome Sciences. Researchers hope further study will lead to personalized reproductive medicine for women, allowing doctors to tailor each woman's treatment and health maintenance strategies to her individual microbial make-up.

4 Jun 2010

Report ranks best children's hospitals

U.S. News & World Report reports on the nation's best children's hospitals: "Out of all of the roughly 5,000 U.S. hospitals, only about 1 in 30 has deep expertise in caring for children with serious problems. For youngsters who need that quality of care, the Best Children's Hospitals rankings showcase the medical centers that see kids every day who have cancer, cystic fibrosis, defective hearts, and countless other life-threatening or rare conditions beyond the capabilities of most hospitals, even those with sizable pediatric departments.

4 Jun 2010

BSGI effective for evaluating unclear mammographic or ultrasound findings

Researchers at the Legacy Good Samaritan Hospital in Portland, Oregon presented data on the clinical use of Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging technique, at the American Society of Breast Surgeons Annual meeting in Las Vegas in April: Breast Specific Gamma Imaging Used As An Adjunct to Mammography.

4 Jun 2010

Study: 10% increase in cigarette pricing can reduce smoking among people with alcohol, drug disorders

A new study from the David Geffen School of Medicine at UCLA suggests that increasing cigarette taxes could be an effective way to reduce smoking among individuals with alcohol, drug or mental disorders.

4 Jun 2010

Detailed analysis of epigenetics of Wilms tumor reveals similarities to stem cells

A detailed analysis of the epigenetics - factors controlling when and in what tissues genes are expressed - of Wilms tumor reveals striking similarities to stem cells normally found in fetal kidneys. These findings by Massachusetts General Hospital Cancer Center researchers have revealed new cellular pathways that are critical for Wilms tumor development and may also apply to other pediatric cancers.

4 Jun 2010

CHOC Children's receives royalty-free research license to certain StemCells' patents

StemCells, Inc. and the Children's Hospital of Orange County ("CHOC Children's") announced today that they have entered into an agreement that provides CHOC Children's with a royalty-free research license to certain of StemCells' patents. This license authorizes CHOC Children's to proliferate, maintain and use human neural stem cells for non-commercial purposes.

4 Jun 2010

Sebelius to highlight geographic differences in Medicare hospital payments

U.S. Health and Human Services Secretary Kathleen Sebelius visits Rochester's Mayo Clinic Thursday morning. ... The visit comes after a recent report that Minnesota will receive money earmarked for states which provide low-cost, high-value health care. But just how much money Minnesota will receive is far from certain. Sebelius is expected to get a first-hand look at the clinic's technology for tracking health care information.

4 Jun 2010

Vermont regulator demands $3 million payback from insurer

Burlington Free Press: "Blue Cross and Blue Shield of Vermont overpaid its former chief executive officer by $3 million over an eight-year period and has been ordered to pay the money back to its subscribers by 2012 in the form of reduced premiums, a top state regulator said Wednesday. The action by the state Banking, Insurance, Securities and Health Care Administration Department follows last year's disclosure that William Milnes, the nonprofit firm's former CEO, received a $7.2 million payout when he stepped down in 2008."

4 Jun 2010

Latest version of LOINC for electronic health information exchange to be released

As the practice, regulation and reimbursement of health care become more complicated, and as the demand for electronic medical records and health information exchange grows, a universal method of identifying test results and other clinical measurement is essential.

4 Jun 2010

USPTO decision confirms validity of Haemonetics' '983 Patent

Haemonetics Corporation announced today that on May 28, 2010, the United States Patent and Trademark Office issued a decision confirming the validity of Haemonetics' '983 Patent in light of numerous prior art references cited by Fenwal Inc. As such, the USPTO explicitly rejected Fenwal's position that the Patent was invalid over the prior art.

4 Jun 2010

Royal Philips Electronics, RXi Pharmaceuticals sign joint research agreement

Royal Philips Electronics and RXi Pharmaceuticals Corporation, a US-based biopharmaceutical company, today announced that they have entered into a joint research agreement to explore the benefits of combining proprietary technologies from both companies for the targeted delivery of experimental therapeutics based on RNA interference.

4 Jun 2010

Ontarians from racialized backgrounds more likely to live in poverty, face barriers to find job: Study

Ontarians from racialized backgrounds are far more likely to live in poverty, face barriers to finding a job, and receive less pay for work, says a study of Census data by the Canadian Centre for Policy Alternatives.

4 Jun 2010

WisTa Laboratories announces collaborative R&D agreement with Bayer Schering Pharma

WisTa Laboratories Ltd, a wholly owned subsidiary of TauRx Pharmaceuticals, announced today that they have entered a collaborative R&D agreement with Bayer Schering Pharma AG, Germany, which could redefine the way Alzheimer's disease (AD) and related disorders are currently being diagnosed and treated.

4 Jun 2010

Poll says more than half of Californians support health overhaul

Half of Californian voters support the new health care law, but many say "it's only a first of many necessary changes," The Associated Press/San Jose Mercury News reports. "In 1,522 telephone surveys of registered voters conducted in April, Field Poll director Mark DiCamillo says 30 percent strongly support the nation's new health care law, and another 22 percent somewhat support it. Compared to previous national polls, the new law is more popular in California than the rest of the country."

4 Jun 2010

SERCA2a gene therapy proves effective in people with advanced heart failure: Researchers

Researchers at Mount Sinai School of Medicine have developed a new gene therapy that is safe and effective in reversing advanced heart failure. SERCA2a (produced as MYDICAR-) is a gene therapy designed to stimulate production of an enzyme that enables the failing heart to pump more effectively.

4 Jun 2010

Government health IT advisers examine privacy policies

One of the latest hurdles government advisers helping to shape health information technology policy must jump is addressing the amount of control patients should have over their own records, Modern Healthcare reports.

4 Jun 2010

PregLem reports positive Phase III data from PEARL I study of Esmya for uterine fibroids

PregLem, the European specialty biopharmaceutical company focused on women's reproductive medicine, announces positive Phase III data from its second pivotal study (PEARL I) for its lead product Esmya (ulipristal acetate), as an effective treatment for uterine fibroids (myoma) - a condition that affects millions of women worldwide.

4 Jun 2010

Millipore shareholders approve acquisition of all outstanding shares of common stock by Merck KGaA

Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced that its shareholders voted at a Special Meeting of Shareholders to approve the previously-announced acquisition of all outstanding shares of common stock of Millipore by Merck KGaA of Germany, the global pharmaceutical and chemical company.

4 Jun 2010

Intellect Neurosciences receives USPTO Notice of Allowance for IN-N01 monoclonal antibody patent

Intellect Neurosciences, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent related to the Company's humanized monoclonal antibody, IN-N01, being developed as a disease-modifying treatment for Alzheimer's disease and other related indications.

4 Jun 2010

Medical News

WHO says H1N1 remains pandemic

Delicate balance of microbes in vagina can vary between healthy women: New study

Report ranks best children's hospitals

BSGI effective for evaluating unclear mammographic or ultrasound findings

Study: 10% increase in cigarette pricing can reduce smoking among people with alcohol, drug disorders

Detailed analysis of epigenetics of Wilms tumor reveals similarities to stem cells

CHOC Children's receives royalty-free research license to certain StemCells' patents

Sebelius to highlight geographic differences in Medicare hospital payments

Vermont regulator demands $3 million payback from insurer

Latest version of LOINC for electronic health information exchange to be released

USPTO decision confirms validity of Haemonetics' '983 Patent

Royal Philips Electronics, RXi Pharmaceuticals sign joint research agreement

Ontarians from racialized backgrounds more likely to live in poverty, face barriers to find job: Study

WisTa Laboratories announces collaborative R&D agreement with Bayer Schering Pharma

Poll says more than half of Californians support health overhaul

SERCA2a gene therapy proves effective in people with advanced heart failure: Researchers

Government health IT advisers examine privacy policies

PregLem reports positive Phase III data from PEARL I study of Esmya for uterine fibroids

Millipore shareholders approve acquisition of all outstanding shares of common stock by Merck KGaA

Intellect Neurosciences receives USPTO Notice of Allowance for IN-N01 monoclonal antibody patent

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News